Envoy Medical (COCH) FCF Margin (2022 - 2026)

Envoy Medical has disclosed FCF Margin across 5 years of filings, most recently posting 15541.03% for Q1 2026.

• FCF Margin for Q1 2026 came in at 15541.03%, down 743016.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 8850.43% (down 84948.0% YoY), and the FY2025 annual result was 7626.56%, up 78633.0% from the prior year.
• FCF Margin came in at 15541.03% for Q1 2026 at Envoy Medical, down from 7809.33% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 1296.25% in Q3 2023 to a low of 15541.03% in Q1 2026.
• The 5-year median for FCF Margin is 8110.87% (2025), against an average of 8271.8%.
• Across the five-year window, FCF Margin soared 1051222 bps in 2023 and sank 804625 bps in 2024, its largest moves.
• Envoy Medical's FCF Margin stood at 12100.0% in 2022, then climbed by 3 bps to 11753.68% in 2023, then climbed by 8 bps to 10850.0% in 2024, then gained by 28 bps to 7809.33% in 2025, then sank by 99 bps to 15541.03% in 2026.
• The last three FCF Margin figures came in at 15541.03% (Q1 2026), 7809.33% (Q4 2025), and 10311.9% (Q3 2025), per Business Quant data.